Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Structural characterization of infection- and vaccination-elicited antibodies in complex with antigen provides insight into the evolutionary arms race between the host and the pathogen and informs rational vaccine immunogen design. We isolated a germline-like monoclonal antibody (mAb) from plasmablasts activated upon mRNA vaccination against SARS-CoV-2 and determined its structure in complex with the spike glycoprotein by cryo-EM. We show that the mAb engages a previously uncharacterized neutralizing epitope on the spike N-terminal domain (NTD). The high-resolution structure reveals details of the intermolecular interactions and shows that the mAb inserts its HCDR3 loop into a hydrophobic NTD cavity previously shown to bind a heme metabolite, biliverdin. We demonstrate direct competition with biliverdin and that - because of the conserved nature of the epitope – the mAb maintains binding to viral variants B.1.1.7 and B.1.351. Our study illustrates the feasibility of targeting the NTD to achieve broad neutralization against SARS-CoV-2 variants.
Article activity feed
-
SciScore for 10.1101/2021.07.08.451649: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Anti-human IgG-Biotin (Abcam) in PBS-T was added to each and incubated for 1hr at RT. Anti-human IgG-Biotinsuggested: NoneAfter 24 hours, cells were permeabilized and stained using an anti-nucleoprotein antibody 1C7 as discussed in detail earlier37,43. anti-nucleoproteinsuggested: NoneRecombinant DNA Sentences Resources Spike proteins for enzyme-linked immunosorbent assay (ELISA) were cloned into a mammalian expression vector, pCAGGS as described earlier37,38 and purified after transient transfections with each respective … SciScore for 10.1101/2021.07.08.451649: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Anti-human IgG-Biotin (Abcam) in PBS-T was added to each and incubated for 1hr at RT. Anti-human IgG-Biotinsuggested: NoneAfter 24 hours, cells were permeabilized and stained using an anti-nucleoprotein antibody 1C7 as discussed in detail earlier37,43. anti-nucleoproteinsuggested: NoneRecombinant DNA Sentences Resources Spike proteins for enzyme-linked immunosorbent assay (ELISA) were cloned into a mammalian expression vector, pCAGGS as described earlier37,38 and purified after transient transfections with each respective plasmid. pCAGGSsuggested: RRID:Addgene_18926)Software and Algorithms Sentences Resources Data were plotted in Prism 9 (GraphPad Software) and area under the curve (AUC) calculated. GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Serial dilutions of the mAb samples were made in 1X minimal essential medium (MEM; Life Technologies) starting at 30 µg/ml. MEMsuggested: (E-mem, RRID:SCR_016081)For the remainder of the spike, a previously published structure (PDB ID 7NTC) was docked into the sharpened full map in UCSF Chimera then manually fit in COOT. COOTsuggested: (Coot, RRID:SCR_014222)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-